() <br /><br /><br /><br /> () <br /><br /><br /><br />Carvalho FA, de Almeida JP, Freitas-Santos T, Saldanha C (2009) <br />Modulation of erythrocyte acetylcholinesterase activity and its association with G protein-band 3 interactions<br /><i>J Membr Biol</i> <b>228</b>: 89<br /><br />Silva AS, Saldanha C, Martins e Silva J (2007) <br />Effects of velnacrine maleate in the leukocyte-endothelial cell interactions in rat cremaster microcirculatory network<br /><i>Clinical Hemorheology Microcirculation</i> <b>36</b>: 235<br /><br />Aparicio I, Callejon M, Bello MA, Jimenez JC, Guiraum A (2003) <br />Spectrofluorimetric determination of velnacrine in human serum and urine<br /><i>Farmaco</i> <b>58</b>: 1257<br /><br /> () <br /><br /><br /><br />Braga MF, Harvey AL, Rowan EG (1991) <br />Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro<br /><i>British Journal of Pharmacology</i> <b>102</b>: 909<br /><br />Natori K, Okazaki Y, Irie T, Katsube J (1990) <br />Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor<br /><i>Japanese Journal of Pharmacology</i> <b>53</b>: 145<br /><br />